Welcome to LookChem.com Sign In|Join Free
  • or
Riboflavin is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

83-88-5

Post Buying Request

83-88-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83-88-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 83-88-5 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 8 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 83-88:
(4*8)+(3*3)+(2*8)+(1*8)=65
65 % 10 = 5
So 83-88-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1

83-88-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (R0020)  Riboflavin  

  • 83-88-5

  • 25g

  • 250.00CNY

  • Detail
  • TCI America

  • (R0020)  Riboflavin  

  • 83-88-5

  • 100g

  • 630.00CNY

  • Detail
  • TCI America

  • (R0020)  Riboflavin  

  • 83-88-5

  • 500g

  • 1,990.00CNY

  • Detail
  • Alfa Aesar

  • (A11764)  Riboflavin, 98%   

  • 83-88-5

  • 25g

  • 168.0CNY

  • Detail
  • Alfa Aesar

  • (A11764)  Riboflavin, 98%   

  • 83-88-5

  • 100g

  • 541.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1054)  Riboflavin  pharmaceutical secondary standard; traceable to USP and PhEur

  • 83-88-5

  • PHR1054-1G

  • 732.19CNY

  • Detail
  • Supelco

  • (47861)  Riboflavin(B2)  analytical standard

  • 83-88-5

  • 000000000000047861

  • 195.39CNY

  • Detail
  • Sigma-Aldrich

  • (R0600000)  Riboflavin  European Pharmacopoeia (EP) Reference Standard

  • 83-88-5

  • R0600000

  • 1,880.19CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000757)  Riboflavinforpeakidentification  European Pharmacopoeia (EP) Reference Standard

  • 83-88-5

  • Y0000757

  • 1,880.19CNY

  • Detail
  • Cerilliant

  • (V-015)  (−)-Riboflavin (Vitamin B2) solution  100 μg/mL (Methanol:0.1% Ammonium acetate in Water (1:1)), ampule of 1 mL, certified reference material

  • 83-88-5

  • V-015-1ML

  • 863.46CNY

  • Detail
  • USP

  • (1603006)  Riboflavin  United States Pharmacopeia (USP) Reference Standard

  • 83-88-5

  • 1603006-500MG

  • 4,662.45CNY

  • Detail

83-88-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Riboflavin (B2)

1.2 Other means of identification

Product number -
Other names Riboflavin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83-88-5 SDS

83-88-5Synthetic route

BARBITURIC ACID
67-52-7

BARBITURIC ACID

N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine
21037-26-3

N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In acetic acid; butan-1-ol for 4h; Heating;74.2%
tetra-O-acetyl riboflavin
752-13-6

tetra-O-acetyl riboflavin

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With calcium methylate
With sodium methylate
1,4-dioxane
123-91-1

1,4-dioxane

BARBITURIC ACID
67-52-7

BARBITURIC ACID

N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine
21037-26-3

N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine

acetic acid
64-19-7

acetic acid

riboflavin
83-88-5

riboflavin

BARBITURIC ACID
67-52-7

BARBITURIC ACID

1-(2-biphenyl-2-ylazo-4,5-dimethyl-anilino)-D-1-deoxy-ribitol
123128-64-3

1-(2-biphenyl-2-ylazo-4,5-dimethyl-anilino)-D-1-deoxy-ribitol

riboflavin
83-88-5

riboflavin

violuric acid
87-39-8

violuric acid

3,4-dimethyl-N-ribitylaniline
3051-94-3

3,4-dimethyl-N-ribitylaniline

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With boric acid
With propionic acid
6,7-dimethyl-8-ribityllumazine
2535-20-8

6,7-dimethyl-8-ribityllumazine

dimethylglyoxal
431-03-8

dimethylglyoxal

riboflavin
83-88-5

riboflavin

4a-Hydroperoxy-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione
83959-96-0

4a-Hydroperoxy-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In water Rate constant;
4a-(1-Hydroxy-ethylperoxy)-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione
132855-95-9

4a-(1-Hydroxy-ethylperoxy)-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione

A

1-hydroxyethylhydroperoxide
19393-68-1

1-hydroxyethylhydroperoxide

B

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In water Rate constant;
4a-(2-Hydroxy-2-methyl-propylperoxy)-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione
132855-96-0

4a-(2-Hydroxy-2-methyl-propylperoxy)-7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxy-pentyl)-5,10-dihydro-4aH-benzo[g]pteridine-2,4-dione

A

peroxy-t-butanol
69515-12-4

peroxy-t-butanol

B

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In water Rate constant;
lampteroflavin
114590-52-2

lampteroflavin

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With hydrogenchloride at 60℃; for 1.33333h;
2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate
71491-00-4

2,5-diamino-6-hydroxy-4-ribitylaminopyrimidine-5'-phosphate

dimethylglyoxal
431-03-8

dimethylglyoxal

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
1) cell extract of Candida guilliermondii ATCC 9058, phosphatase; 2) riboflavin synthase; Yield given. Multistep reaction;
dimethylglyoxal
431-03-8

dimethylglyoxal

2,5-Diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate
71491-00-4

2,5-Diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With phosphate buffer; 1,4-dithio-erythritol; pyrimidine deaminase; riboflavin synthase; magnesium chloride; alkaline phosphatase 1.) 1 h, 37 deg C, 2.) 3 h, 37 deg C; Yield given. Multistep reaction;
riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With HEPES buffer; Hg(II)*EDTA In water at 30℃; Rate constant; at pH 7.4;
With C12H13O2(CH3)3(O)(OO) In acetonitrile at 37℃; for 0.166667h; pH=7.4; aq. phosphate buffer; Inert atmosphere;100 %Spectr.
With Lactococcus lactis dihydroorotate dehydrogenase; oxygen Kinetics; Reagent/catalyst; Enzymatic reaction;
pyrimidine-2,4,5,6(1H,3H)-tetraone
61066-33-9, 61066-34-0, 61066-35-1, 61127-23-9

pyrimidine-2,4,5,6(1H,3H)-tetraone

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With boric acid; acetic acid
With ethanol; tin(ll) chloride
With ethanol; hydrogen sulfide
With boric acid; acetic acid
5,5-Dichloro-barbituric acid
699-40-1

5,5-Dichloro-barbituric acid

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With pyridine
5,5-dibromobarbituric acid
511-67-1

5,5-dibromobarbituric acid

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

1-<2-amino-4,5-dimethyl-anilino>-D-1-deoxy-ribitol

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With acetic acid
N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine
21037-26-3

N-<3,4-dimethyl-6-(phenylazo)phenyl>-D-ribitylamine

5,5'-dihydroxy-<5,5'>bipyrimidinyl-2,4,6,2',4',6'-hexaone

5,5'-dihydroxy-<5,5'>bipyrimidinyl-2,4,6,2',4',6'-hexaone

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With hydrogenchloride; palladium on activated charcoal; nitrogen anschliessenden Einwirken von Luft auf die Reaktionsloesung;
<4,5-dimethyl-2-D-ribitol-1-ylamino-phenyl>-carbamic acid ethyl ester

<4,5-dimethyl-2-D-ribitol-1-ylamino-phenyl>-carbamic acid ethyl ester

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With sodium hydroxide Erwaermen des Reaktionsprodukts mit Alloxan in wss. HCl bzw. in Essigsaeure unter Zusatz von Natriumacetat und H3BO3;
With potassium hydroxide Erwaermen des Reaktionsprodukts mit Alloxan in wss. HCl bzw. in Essigsaeure unter Zusatz von Natriumacetat und H3BO3;
hydrogenchloride
7647-01-0

hydrogenchloride

flavin adenine dinucleotide
146-14-5

flavin adenine dinucleotide

A

lumiflavin
1088-56-8

lumiflavin

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

C

Flavin mononucleotide
146-17-8

Flavin mononucleotide

D

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
Adenin, O5-Phosphono-D-ribose und H3PO4;
water
7732-18-5

water

flavin adenine dinucleotide
146-14-5

flavin adenine dinucleotide

A

lumiflavin
1088-56-8

lumiflavin

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

C

Flavin mononucleotide
146-17-8

Flavin mononucleotide

D

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
vom pH 3-9;
bei der Einwirkung von Sonnenlicht;
Flavin mononucleotide
146-17-8

Flavin mononucleotide

A

lumiflavin
1088-56-8

lumiflavin

B

riboflavin
83-88-5

riboflavin

C

lumichrome

lumichrome

Conditions
ConditionsYield
mit sichtbares oder ultraviolettes Licht.Irradiation;
riboflavin

riboflavin

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With Escherichia coli ribonucleotide reductase active-R2 form In phosphate buffer at 22℃; pH=7.0; Kinetics; Further Variations:; Reagents; Oxidation;
riboflavin

riboflavin

A

RFH2
13345-95-4

RFH2

B

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In phosphate buffer at 22℃; pH=7.0; Kinetics; disproportionation;
6,7-dimethyl-8-ribityllumazine
2535-20-8

6,7-dimethyl-8-ribityllumazine

A

5-amino-6-(D-ribitylamino)uracil
14036-89-6, 17014-74-3

5-amino-6-(D-ribitylamino)uracil

B

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With ethylenediaminetetraacetic acid; riboflavin synthase from Escherichia coli; 5-(4-phosphonobutyryl)amino-6-D-ribitylaminouracil In phosphate buffer Enzyme kinetics; Further Variations:; Reagents;
With Tris hydrochloride buffer; sodium chloride In dimethyl sulfoxide at 27℃; pH=7.0; Enzyme kinetics; Further Variations:; Reagents;
With recombinant Mycobacterium tuberculosis riboflavin synthase; 2-(2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)ethyl dihydrogen phosphate; water; tris hydrochloride; sodium chloride; D,L-dithiothreitol In dimethyl sulfoxide at 27℃; for 0.5h; pH=7; Kinetics; Reagent/catalyst; aq. buffer; Enzymatic reaction;
3,4-dimethyl-N-ribitylaniline
3051-94-3

3,4-dimethyl-N-ribitylaniline

A

riboflavin
83-88-5

riboflavin

B

Na2S2O4

Na2S2O4

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) 34percent aq. HCl, 40percent aq. sodium nitrite, 2.) 20percent aq. sodium acetate / 1.) 15-20 deg C, 2.) 2 h
2: 74.2 percent / butan-1-ol; acetic acid / 4 h / Heating
View Scheme
3,4-dimethyl-N-ribitylaniline
3051-94-3

3,4-dimethyl-N-ribitylaniline

riboflavin
83-88-5

riboflavin

L-ribo-5-(3.4-dimethyl-anilino)-1.2.3.4-tetraacetoxy-pentane
911650-71-0

L-ribo-5-(3.4-dimethyl-anilino)-1.2.3.4-tetraacetoxy-pentane

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: und Behandlung des Reaktionsprodukts mit Natriummethylat in Methanol
View Scheme
Multi-step reaction with 2 steps
1: und Behandlung des Reaktionsprodukts mit Natriummethylat in Methanol
View Scheme
BARBITURIC ACID
67-52-7

BARBITURIC ACID

1-N-D-ribitylamino-3,4-dimethyl-6-phenylazobenzene
21037-26-3, 113473-93-1

1-N-D-ribitylamino-3,4-dimethyl-6-phenylazobenzene

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
With Trimethylacetic acid In 2-methyl-propan-1-ol
In 2-methyl-propan-1-ol
In 2-methyl-propan-1-ol
BARBITURIC ACID
67-52-7

BARBITURIC ACID

2-methylpropyl acetate
110-19-0

2-methylpropyl acetate

1-N-D-ribitylamino-3,4-dimethyl-6-phenylazobenzene
21037-26-3, 113473-93-1

1-N-D-ribitylamino-3,4-dimethyl-6-phenylazobenzene

riboflavin
83-88-5

riboflavin

Conditions
ConditionsYield
In 2-methyl-propan-1-ol; acetic acid
acetic anhydride
108-24-7

acetic anhydride

riboflavin
83-88-5

riboflavin

tetra-O-acetyl riboflavin
752-13-6

tetra-O-acetyl riboflavin

Conditions
ConditionsYield
With pyridine at 120℃; for 0.333333h;99%
With perchloric acid In acetic acid at 40℃; for 0.5h;95%
With perchloric acid In acetic acid at 40℃; for 1h; Inert atmosphere;95%
riboflavin
83-88-5

riboflavin

Formylmethylflavin
4250-90-2

Formylmethylflavin

Conditions
ConditionsYield
Stage #1: riboflavin With sulfuric acid; periodic acid In water at 0℃; for 0.5h; Darkness;
Stage #2: With sodium carbonate In water at 18 - 25℃; pH=3.8 - 3.9;
94%
Stage #1: riboflavin With sulfuric acid; periodic acid at 20℃; for 1h;
Stage #2: In toluene Heating; Further stages.;
49%
With sulfuric acid; periodic acid unter Liehtausschluss;
benzaldehyde dimethyl acetal
1125-88-8

benzaldehyde dimethyl acetal

riboflavin
83-88-5

riboflavin

10-(2,6-diphenyl-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-ylmethyl)-7,8-dimethyl-10H-benzo[g]pteridine-2,4-dione

10-(2,6-diphenyl-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-ylmethyl)-7,8-dimethyl-10H-benzo[g]pteridine-2,4-dione

Conditions
ConditionsYield
With camphor-10-sulfonic acid In N,N-dimethyl-formamide Etherification;90%
(triethylphosphine)chlorogold(I)
15529-90-5

(triethylphosphine)chlorogold(I)

riboflavin
83-88-5

riboflavin

(C2H5)3PAu(C17H19N4O6)*H2O
97860-53-2

(C2H5)3PAu(C17H19N4O6)*H2O

Conditions
ConditionsYield
With NaOH; H2O In water addn. of solid Et3PAuCl to a soln. of riboflavin in aq. NaOH; the mixt.was shaken for 5 min.;; the ppt. was filtered off, washed with H2O, acetone, and Et2O, and dried under vac.; elem. anal.;;90%
riboflavin
83-88-5

riboflavin

10-(2,2-dihydroxylethyl)-7,8-dimethylisoalloxazine
825630-94-2

10-(2,2-dihydroxylethyl)-7,8-dimethylisoalloxazine

Conditions
ConditionsYield
With sodium periodate In water at 25℃; for 17h;86%
With sodium periodate In water at 20℃; for 16h; Darkness;76%
With sodium periodate
With sodium periodate In water for 3h;
With sodium periodate In water at 20℃;
riboflavin
83-88-5

riboflavin

6,7-dimethyl-1-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)-1,4-dihydroquinoxaline-2,3-dione
18650-70-9

6,7-dimethyl-1-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)-1,4-dihydroquinoxaline-2,3-dione

Conditions
ConditionsYield
Stage #1: riboflavin With sodium hydroxide at 90℃; for 1h;
Stage #2: With dihydrogen peroxide In water at 0 - 20℃; for 12h;
84%
Multi-step reaction with 2 steps
1.1: sodium hydroxide / 1 h / 90 °C / Inert atmosphere
1.2: 0 °C / pH 3 / Inert atmosphere
2.1: sodium hydroxide; dihydrogen peroxide / water / 12 h / 0 - 20 °C / Inert atmosphere
View Scheme
phenylacetic acid
103-82-2

phenylacetic acid

riboflavin
83-88-5

riboflavin

tetraphenylacetyl riboflavin
1043592-39-7

tetraphenylacetyl riboflavin

Conditions
ConditionsYield
With pyridine; trichlorophosphate at 73℃; for 4.5h; Inert atmosphere;82%
acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

riboflavin
83-88-5

riboflavin

tetra-O-acetyl riboflavin
752-13-6

tetra-O-acetyl riboflavin

Conditions
ConditionsYield
With perchloric acid at 45℃; for 0.666667h; Schlenk technique;80%
With perchloric acid
BOC-glycine
4530-20-5

BOC-glycine

riboflavin
83-88-5

riboflavin

tert-butoxycarbonylaminoacetic acid 2,3,4-tris-(2-tert-butoxycarbonylamino-acetoxy)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydro-2H-benzo[g]pteridin-10-yl)-pentyl ester

tert-butoxycarbonylaminoacetic acid 2,3,4-tris-(2-tert-butoxycarbonylamino-acetoxy)-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydro-2H-benzo[g]pteridin-10-yl)-pentyl ester

Conditions
ConditionsYield
With dmap; triethylamine; diisopropyl-carbodiimide In N,N-dimethyl-formamide at 50℃; Darkness; Inert atmosphere;78%
riboflavin
83-88-5

riboflavin

6,7-dimethyl-3-oxo-4-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)-3,4-dihydroquinoxaline-2-carboxylic acid
64480-68-8

6,7-dimethyl-3-oxo-4-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)-3,4-dihydroquinoxaline-2-carboxylic acid

Conditions
ConditionsYield
Stage #1: riboflavin With sodium hydroxide at 90℃; for 1h; Inert atmosphere;
Stage #2: With sulfuric acid In water at 0℃; pH=3; Inert atmosphere;
74%
Stage #1: riboflavin With water; sodium hydroxide at 90℃; for 2h;
Stage #2: With acetic acid at 20℃; pH=6;
41 g
acetone
67-64-1

acetone

riboflavin
83-88-5

riboflavin

7,8-dimethyl-10-(((4S,4'R,5S)-2,2,2',2'-tetramethyl-[4,4'-bi(1,3-dioxolan)]-5-yl)methyl)benzo[g]pteridine-2,4(3H,10H)-dione
95985-96-9

7,8-dimethyl-10-(((4S,4'R,5S)-2,2,2',2'-tetramethyl-[4,4'-bi(1,3-dioxolan)]-5-yl)methyl)benzo[g]pteridine-2,4(3H,10H)-dione

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 20℃; for 72h;72%
riboflavin
83-88-5

riboflavin

lumichrome
1086-80-2

lumichrome

Conditions
ConditionsYield
With sodium periodate In water at 50℃; for 24h;70%
With sodium periodate In water at 50℃; for 24h;70%
With methanol; air
n-hexadecanoyl chloride
112-67-4

n-hexadecanoyl chloride

riboflavin
83-88-5

riboflavin

tetra-O-palmitoyl riboflavin
752-75-0

tetra-O-palmitoyl riboflavin

Conditions
ConditionsYield
With dmap at 40℃; for 12h; Inert atmosphere;67%
trityl chloride
76-83-5

trityl chloride

riboflavin
83-88-5

riboflavin

5'-O-Trityl riboflavin
136738-76-6

5'-O-Trityl riboflavin

Conditions
ConditionsYield
With pyridine at 110℃; for 1h;64%
In pyridine at 110℃; for 4h;63.4%
With pyridine
acetaldehyde
75-07-0

acetaldehyde

riboflavin
83-88-5

riboflavin

5-ethyl-1,5-dihydroriboflavin
1083303-50-7

5-ethyl-1,5-dihydroriboflavin

Conditions
ConditionsYield
With palladium 10% on activated carbon; water; hydrogen In ethanol at 20℃; for 168h;62%
4-vinylbenzaldehyde diethyl acetal
93429-66-4

4-vinylbenzaldehyde diethyl acetal

riboflavin
83-88-5

riboflavin

2',4'-p-vinylbenzylideneribo flavin

2',4'-p-vinylbenzylideneribo flavin

Conditions
ConditionsYield
With p-toluenesulfonic acid monohydrate; hydroquinone In N,N-dimethyl-formamide at 80℃; for 3h; Inert atmosphere;56%
benzaldehyde dimethyl acetal
1125-88-8

benzaldehyde dimethyl acetal

riboflavin
83-88-5

riboflavin

10-[(2S,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-phenyl-1,3-dioxan-4-yl]methyl-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione
278793-03-6

10-[(2S,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-phenyl-1,3-dioxan-4-yl]methyl-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione

Conditions
ConditionsYield
With camphor-10-sulfonic acid In N,N-dimethyl-formamide Etherification;50%
With (1S)-10-camphorsulfonic acid In N,N-dimethyl-formamide at 80℃; Darkness;22%
With camphor-10-sulfonic acid In N,N-dimethyl-formamide at 50℃; under 45.0045 Torr; for 16h;14%
13C10/15N5-adenosine triphosphate

13C10/15N5-adenosine triphosphate

riboflavin
83-88-5

riboflavin

C17(13)C10H33N4(15)N5O15P2

C17(13)C10H33N4(15)N5O15P2

Conditions
ConditionsYield
With Phosphocreatine; creatine phosphokinase from rabbit muscle; corynebacterium ammoniagenes FAD synthetase; 2-amino-2-hydroxymethyl-1,3-propanediol; magnesium chloride In aq. buffer at 25℃; for 24h; pH=7.6; Enzymatic reaction;47%
mono-4-methoxytrityl chloride
14470-28-1

mono-4-methoxytrityl chloride

riboflavin
83-88-5

riboflavin

C37H36N4O7

C37H36N4O7

Conditions
ConditionsYield
With pyridine at 100℃; Inert atmosphere;44%
[2,8-3H]ATP

[2,8-3H]ATP

riboflavin
83-88-5

riboflavin

C27H31(3)H2N9O15P2

C27H31(3)H2N9O15P2

Conditions
ConditionsYield
With Phosphocreatine; creatine phosphokinase from rabbit muscle; corynebacterium ammoniagenes FAD synthetase; ATP; 2-amino-2-hydroxymethyl-1,3-propanediol; magnesium chloride In aq. buffer at 25℃; for 24h; pH=7.6; Enzymatic reaction;40%
n-dodecanoyl chloride
112-16-3

n-dodecanoyl chloride

riboflavin
83-88-5

riboflavin

5'-lauric acid monoester of riboflavin

5'-lauric acid monoester of riboflavin

Conditions
ConditionsYield
With pyridine; triethylamine In 1,4-dioxane; water at 5 - 10℃; for 0.583333h;38.9%
4,4'-dimethoxytrityl chloride
40615-36-9

4,4'-dimethoxytrityl chloride

riboflavin
83-88-5

riboflavin

10-(5-(bis(4-methoxyphenyl)(phenyl)-methoxy)-2,3,4-trihydroxypentyl)-7,8-dimethylbenzo[g]-pteridine-2,4(3H,10H)-dione

10-(5-(bis(4-methoxyphenyl)(phenyl)-methoxy)-2,3,4-trihydroxypentyl)-7,8-dimethylbenzo[g]-pteridine-2,4(3H,10H)-dione

Conditions
ConditionsYield
With pyridine; dmap; triethylamine at 20℃; Inert atmosphere;35%
2,2,2-trichloroethyl butyrate
57392-44-6

2,2,2-trichloroethyl butyrate

riboflavin
83-88-5

riboflavin

riboflavin 5'-monobutyrate
20704-80-7

riboflavin 5'-monobutyrate

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 45℃; for 144h; subtilisin;25%
C28H36N10O15P4

C28H36N10O15P4

riboflavin
83-88-5

riboflavin

C31H39N9O14P2
740066-94-8

C31H39N9O14P2

Conditions
ConditionsYield
In dimethyl sulfoxide at 65℃;12.5%
butanoic acid anhydride
106-31-0

butanoic acid anhydride

riboflavin
83-88-5

riboflavin

A

riboflavin 5'-monobutyrate
20704-80-7

riboflavin 5'-monobutyrate

B

riboflavin 2’,3’,4’,5’-tetrabutanoate
752-56-7

riboflavin 2’,3’,4’,5’-tetrabutanoate

Conditions
ConditionsYield
With pyridine at 37℃; for 14h;A 10%
B n/a
palmitic anhydride
623-65-4

palmitic anhydride

riboflavin
83-88-5

riboflavin

riboflavin-5'-monopalmitate
73130-89-9

riboflavin-5'-monopalmitate

Conditions
ConditionsYield
With pyridine at 120 - 140℃; for 3h;9.8%

83-88-5Relevant academic research and scientific papers

Studies on the reaction between reduced riboflavin and selenocystine

Dereven'kov, Ilia A.,Makarov, Sergei V.,Molodtsov, Pavel A.,Makarova, Anna S.

, p. 146 - 153 (2020/09/21)

Selenocysteine (Sec) is a crucial component of mammalian thioredoxin reductase (TrxR) where it serves as a nucleophile for disulfide bond rupture in thioredoxin (Trx). Generation of the reduced state of Sec in TrxR requires consecutive two electron transfer steps, namely: (i) from NADPH to flavin adenine dinucleotide, (ii) from reduced flavin to the disulfide bond Cys59-S-S-Cys64, and finally (iii) from Cys59 and Cys64 to the selenosulfide bond Cys497-S-Se-Sec498. In this work, we studied the reaction between reduced riboflavin (RibH2) and selenocystine (Sec-Sec), an oxidized form of Sec. The interaction between RibH2 and Sec-Sec proceeded relatively slowly in comparison with its reverse reaction, that is, reduction of riboflavin (Rib) by Sec. The rate constant for the reaction between RibH2 and Sec-Sec was (7.9?±?0.1)?×?10?2?M?1 s?1 (pH 7.0, 25.0°C). The reaction between Rib and Sec proceeded via two steps, namely, a rapid reversible binding of Rib to Sec having a protonated selenol group to form a Sec-Rib complex, followed by nucleophilic attack of Sec-Rib by a second Sec molecule harboring a deprotonated selenol group. The equilibrium constant for the overall reduction process of Rib by Sec is (1.2?±?0.1)?×?106?M?1 (25.0°C). The finding that the interaction of RibH2 with oxidized selenol is reversible with its equilibrium favored toward the reverse reaction provides an additional explanation for the exceptional mechanism of the mammalian Trx/TrxR system involving transient reduction of a disulfide bond.

A high-throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis

Serer, María Inés,Carrica, Mariela del Carmen,Trappe, J?rg,López Romero, Sandra,Bonomi, Hernán Ruy,Klinke, Sebastián,Cerutti, María Laura,Goldbaum, Fernando Alberto

, p. 2522 - 2535 (2019/04/17)

Brucella spp. are pathogenic intracellular Gram-negative bacteria adapted to life within cells of several mammals, including humans. These bacteria are the causative agent of brucellosis, one of the zoonotic infections with the highest incidence in the world and for which a human vaccine is still unavailable. Current therapeutic treatments against brucellosis are based on the combination of two or more antibiotics for prolonged periods, which may lead to antibiotic resistance in the population. Riboflavin (vitamin B2) is biosynthesized by microorganisms and plants but mammals, including humans, must obtain it from dietary sources. Owing to the absence of the riboflavin biosynthetic enzymes in animals, this pathway is nowadays regarded as a rich resource of targets for the development of new antimicrobial agents. In this work, we describe a high-throughput screening approach to identify inhibitors of the enzymatic activity of riboflavin synthase, the last enzyme in this pathway. We also provide evidence for their subsequent validation as potential drug candidates in an in?vitro brucellosis infection model. From an initial set of 44?000 highly diverse low molecular weight compounds with drug-like properties, we were able to identify ten molecules with 50% inhibitory concentrations in the low micromolar range. Further Brucella culture and intramacrophagic replication experiments showed that the most effective bactericidal compounds share a 2-Phenylamidazo[2,1-b][1,3]benzothiazole chemical scaffold. Altogether, these findings set up the basis for the subsequent lead optimization process and represent a promising advancement in the pursuit of novel and effective antimicrobial compounds against brucellosis.

Site-Selective Synthesis of 15N- and 13C-Enriched Flavin Mononucleotide Coenzyme Isotopologues

Neti, Syam Sundar,Poulter, C. Dale

, p. 5087 - 5092 (2016/07/06)

Flavin mononucleotide (FMN) is a coenzyme for numerous proteins involved in key cellular and physiological processes. Isotopically labeled flavin is a powerful tool for studying the structure and mechanism of flavoenzyme-catalyzed reactions by a variety of techniques, including NMR, IR, Raman, and mass spectrometry. In this report, we describe the preparation of labeled FMN isotopologues enriched with 15N and 13C isotopes at various sites in the pyrazine and pyrimidine rings of the isoalloxazine core of the cofactor from readily available precursors by a five-step chemo-enzymatic synthesis.

Single label comparative hybridization

-

, (2015/01/06)

The present invention provides methods of detecting and mapping chromosomal or genetic abnormalities associated with various diseases or with predisposition to various diseases, or to detecting the phenomena of large scale copy number variants. In particular, the present invention provides advanced methods of performing array-based comparative hybridization that allow reproducibility between samples and enhanced sensitivity by using the same detectable label for both test sample and reference sample nucleic acids. Invention methods are useful for the detection or diagnosis of particular disease conditions such as cancer, and detecting predisposition to cancer based on detection of chromosomal or genetic abnormalities and gene expression level. Invention methods are also useful for the detection or diagnosis of hereditary genetic disorders or predisposition thereto, especially in prenatal samples. Moreover, invention methods are also useful for the detection or diagnosis of de novo genetic aberrations associated with post-natal developmental abnormalities.

A solid-state pH sensor for nonaqueous media including ionic liquids

Thompson, Brianna C.,Winther-Jensen, Orawan,Winther-Jensen, Bjorn,Macfarlane, Douglas R.

, p. 3521 - 3525 (2013/05/22)

We describe a solid state electrode structure based on a biologically derived proton-active redox center, riboflavin (RFN). The redox reaction of RFN is a pH-dependent process that requires no water. The electrode was fabricated using our previously described 'stuffing' method to entrap RFN into vapor phase polymerized poly(3,4-ethylenedioxythiophene). The electrode is shown to be capable of measuring the proton activity in the form of an effective pH over a range of different water contents including nonaqueous systems and ionic liquids (ILs). This demonstrates that the entrapment of the redox center facilitates direct electron communication with the polymer. This work provides a miniaturizable system to determine pH (effective) in nonaqueous systems as well as in ionic liquids. The ability to measure pH (effective) is an important step toward the ability to customize ILs with suitable pH (effective) for catalytic reactions and biotechnology applications such as protein preservation.

Nucleic acid size detection method

-

, (2012/05/04)

The present invention provides methods of determining the size of a particular nucleic acid segment of interest in a sample of nucleic acids through fragmentation of DNA, size fractionation, an optional second fragmentation, and identification using a marker sequence. In particular aspects, an expansion or reduction of tandem repeat sequences can be detected. In further aspects, carriers and individuals afflicted with fragile X syndrome or other diseases associated with tandem repeats can be distinguished from normal individuals.

O-nucleoside, S-nucleoside, and N-nucleoside probes of lumazine synthase and riboflavin synthase

Talukdar, Arindam,Zhao, Yujie,Lv, Wei,Bacher, Adelbert,Illarionov, Boris,Fischer, Markus,Cushman, Mark

experimental part, p. 6239 - 6261 (2012/09/25)

Lumazine synthase catalyzes the penultimate step in the biosynthesis of riboflavin, while riboflavin synthase catalyzes the last step. O-Nucleoside, S-nucleoside, and N-nucleoside analogues of hypothetical lumazine biosynthetic intermediates have been synthesized in order to obtain structure and mechanism probes of these two enzymes, as well as inhibitors of potential value as antibiotics. Methods were devised for the selective cleavage of benzyl protecting groups in the presence of other easily reduced functionality by controlled hydrogenolysis over Lindlar catalyst. The deprotection reaction was performed in the presence of other reactive functionality including nitro groups, alkenes, and halogens. The target compounds were tested as inhibitors of lumazine synthase and riboflavin synthase obtained from a variety of microorganisms. In general, the S-nucleosides and N-nucleosides were more potent than the corresponding O-nucleosides as lumazine synthase and riboflavin synthase inhibitors, while the C-nucleosides were the least potent. A series of molecular dynamics simulations followed by free energy calculations using the Poisson-Boltzmann/surface area (MM-PBSA) method were carried out in order to rationalize the results of ligand binding to lumazine synthase, and the results provide insight into the dynamics of ligand binding as well as the molecular forces stabilizing the intermediates in the enzyme-catalyzed reaction.

Oxygen reactivity in flavoenzymes: Context matters

McDonald, Claudia A.,Fagan, Rebecca L.,Collard, Francois,Monnier, Vincent M.,Palfey, Bruce A.

supporting information; experimental part, p. 16809 - 16811 (2011/12/04)

Many flavoenzymes-oxidases and monooxygenases-react faster with oxygen than free flavins do. There are many ideas on how enzymes cause this. Recent work has focused on the importance of a positive charge near N5 of the reduced flavin. Fructosamine oxidase has a lysine near N5 of its flavin. We measured a rate constant of 1.6 × 105 M-1 s-1 for its reaction with oxygen. The Lys276Met mutant reacted with a rate constant of 291 M-1 s-1, suggesting an important role for this lysine in oxygen activation. The dihydroorotate dehydrogenases from E. coli and L. lactis also have a lysine near N5 of the flavin. They react with O2 with rate constants of 6.2 × 104 and 3.0 × 103 M-1 s-1, respectively. The Lys66Met and Lys43Met mutant enzymes react with rate constants that are nearly the same as those for the wild-type enzymes, demonstrating that simply placing a positive charge near N5 of the flavin does not guarantee increased oxygen reactivity. Our results show that the lysine near N5 does not exert an effect without an appropriate context; evolution did not find only one mechanism for activating the reaction of flavins with O2.

Aerobic reduction of olefins by in situ generation of diimide with synthetic flavin catalysts

Imada, Yasushi,Iida, Hiroki,Kitagawa, Takahiro,Naota, Takeshi

body text, p. 5908 - 5920 (2011/07/07)

A versatile reducing agent, diimide, can be generated efficiently by the aerobic oxidation of hydrazine with neutral and cationic synthetic flavin catalysts 1 and 2. This technique provides a convenient and safe method for the aerobic reduction of olefins, which proceeds with 1 equiv of hydrazine under an atmosphere of O2 or air. The synthetic advantage over the conventional gas-based method has been illustrated through high hydrazine efficiency, easy and safe handling, and characteristic chemoselectivity. Vitamin B2 derivative 6 acts as a highly practical, robust catalyst for this purpose because of its high availability and recyclability. Association complexes of 1b with dendritic 2,5-bis(acylamino)pyridine 15 exhibit unprecedented catalytic activities, with the reduction of aromatic and hydroxy olefins proceeding significantly faster when a higher-generation dendrimer is used as a host pair for the association catalysts. Contrasting retardation is observed upon similar treatment of non-aromatic or non-hydroxy olefins with the dendrimer catalysts. Control experiments and kinetic studies revealed that these catalytic reactions include two independent, anaerobic and aerobic, processes for the generation of diimide from hydrazine. Positive and negative dendrimer effects on the catalytic reactions have been ascribed to the specific inclusion of hydrazine and olefinic substrates into the enzyme-like reaction cavities of the association complex catalysts. Copyright

Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: Relationship with flavoenzyme function and antimalarial mechanism of action

Haynes, Richard K.,Chan, Wing-Chi,Wong, Ho-Ning,Li, Ka-Yan,Wu, Wai-Keung,Fan, Kit-Man,Sung, Herman H. Y.,Williams, Ian D.,Prosperi, Davide,Melato, Sergio,Coghi, Paolo,Monti, Diego

experimental part, p. 1282 - 1299 (2011/01/04)

The antimalarial drug methylene blue (MB) affects the redox behaviour of parasite flavin-dependent disulfide reductases such as glutathione reductase (GR) that control oxidative stress in the malaria parasite. The reduced flavin adenine dinucleotide cofactor FADH2 initiates reduction to leucomethylene blue (LMB), which is oxidised by oxygen to generate reactive oxygen species (ROS) and MB. MB then acts as a subversive substrate for NADPH normally required to regenerate FADH2 for enzyme function. The synergism between MB and the peroxidic antimalarial artemisinin derivative artesunate suggests that artemisinins have a complementary mode of action. We find that artemisinins are transformed by LMB generated from MB and ascorbic acid (AA) or N-benzyldihydronicotinamide (BNAH) in situ in aqueous buffer at physiological pH into single electron transfer (SET) rearrangement products or two-electron reduction products, the latter of which dominates with BNAH. Neither AA nor BNAH alone affects the artemisinins. The AA-MB SET reactions are enhanced under aerobic conditions, and the major products obtained here are structurally closely related to one such product already reported to form in an intracellular medium. A ketyl arising via SET with the artemisinin is invoked to explain their formation. Dihydroflavins generated from riboflavin (RF) and FAD by pretreatment with sodium dithionite are rapidly oxidised by artemisinin to the parent flavins. When catalytic amounts of RF, FAD, and other flavins are reduced in situ by excess BNAH or NAD(P)H in the presence of the artemisinins in the aqueous buffer, they are rapidly oxidised to the parent flavins with concomitant formation of twoelectron reduction products from the artemisinins; regeneration of the reduced flavin by excess reductant maintains a catalytic cycle until the artemisinin is consumed. In preliminary experiments, we show that NADPH consumption in yeast GR with redox behaviour similar to that of parasite GR is enhanced by artemisinins, especially under aerobic conditions. Recombinant human GR is not affected. Artemisinins thus may act as antimalarial drugs by perturbing the redox balance within the malaria parasite, both by oxidising FADH2 in parasite GR or other parasite flavoenzymes, and by initiating autoxidation of the dihydroflavin by oxygen with generation of ROS. Reduction of the artemisinin is proposed to occur via hydride transfer from LMB or the dihydroflavin to O1 of the peroxide. This hitherto unrecorded reactivity profile conforms with known structure-activity relationships of artemisinins, is consistent with their known ability to generate ROS in vivo, and explains the synergism between artemisinins and redox-active antimalarial drugs such as MB and doxorubicin. As the artemisinins appear to be relatively inert towards human GR, a putative model that accounts for the selective potency of artemisinins towards the malaria parasite also becomes apparent. Decisively, ferrous iron or carbon-centered free radicals cannot be involved, and the reactivity described herein reconciles disparate observations that are incompatible with the ferrous iron-carbon radical hypothesis for antimalarial mechanism of action. Finally, the urgent enquiry into the emerging resistance of the malaria parasite to artemisinins may now in one part address the possibilities either of structural changes taking place in parasite flavoenzymes that render the flavin cofactor less accessible to artemisinins or of an enhancement in the ability to use intra-erythrocytic human disulfide reductases required for maintenance of parasite redox balance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 83-88-5